Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SRDX - Surmodics reports successful first patient uses of Sublime radial access platform devices


SRDX - Surmodics reports successful first patient uses of Sublime radial access platform devices

Surmodics (SRDX) announces the successful first uses with patients for two devices within its Sublime Radial Access Platform: the Sublime Radial Access Guide Sheath and Sublime Radial Access .014 RX PTA Dilatation Catheter. Both Sublime products in multiple cases, including a below-the-knee procedure showcased benefits. "... Delivery of the catheter was easy, even below-the-knee. The pushability, trackability, and crossability all were exceptional. We performed multiple inflations in the below-the-knee case and the crossing profile of the balloon was impeccable,” said Dr. Ibrahim. The Sublime Radial Access .014 RX PTA Catheter which received FDA 510(k) clearance in August 2020, allows above or below-the-knee access through a transradial approach by providing the longest working length (250 cm) on the market.The device is compatible with a 5 Fr guide sheath and is designed to provide the performance of an over-the-wire PTA catheter in an RX platform. The FDA-cleared Sublime Radial Access Guide Sheath

For further details see:

Surmodics reports successful first patient uses of Sublime radial access platform devices
Stock Information

Company Name: Surmodics Inc.
Stock Symbol: SRDX
Market: NASDAQ
Website: surmodics.com

Menu

SRDX SRDX Quote SRDX Short SRDX News SRDX Articles SRDX Message Board
Get SRDX Alerts

News, Short Squeeze, Breakout and More Instantly...